| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 1, Issue 3 229-234, Copyright © 1992 by American Association for Cancer Research
ARTICLES |
CP Wild, GJ Hudson, G Sabbioni, B Chapot, AJ Hall, GN Wogan, H Whittle, R Montesano and JD Groopman
International Agency for Research on Cancer, Lyon, France.
Aflatoxin is implicated as a risk factor for hepatocellular carcinoma in areas of the world with a high incidence of this tumor. The present study was designed to validate the use of aflatoxin-albumin adducts in peripheral blood as a measure of individual exposure to this carcinogen. Dietary intake of aflatoxin was measured at the individual level in 20 residents of Keneba, West Kiang, The Gambia, over a 7-day period and correlated with the level of aflatoxin bound to peripheral blood albumin at the beginning and end of the study. Complementary enzyme-linked immunosorbent assay and high-performance liquid chromatography-fluorescence techniques were used to assay the aflatoxin adducts. All subjects were exposed to aflatoxin originating from several food types, with an average daily intake of 1.4 micrograms/day. A significant correlation (r = 0.55; P = < 0.05) was observed between the dietary intake and the level of albumin-bound aflatoxin at the end of the study. In addition, a good agreement was obtained with the two analytical techniques. A comparison of matched chronic hepatitis B surface antigen carriers with noncarriers did not reveal any difference in adduct formation for a given dietary intake of aflatoxin. These studies demonstrate the validity of aflatoxin-albumin adducts as a marker of human exposure to this carcinogen.
This article has been cited by other articles:
![]() |
P. F. Scholl and J. D. Groopman Long-term Stability of Human Aflatoxin B1 Albumin Adducts Assessed by Isotope Dilution Mass Spectrometry and High-Performance Liquid Chromatography-Fluorescence Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1436 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Peng, L.-Q. Li, M.-H. Peng, Z.-M. Liu, T.-W. Liu, Y. Guo, K.-Y. Xiao, Z. Qin, X.-P. Ye, X.-S. Mo, et al. Evaluation of oxidative stress in a group of adolescents exposed to a high level of aflatoxin B1 a multi-center and multi-biomarker study Carcinogenesis, November 1, 2007; 28(11): 2347 - 2354. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Chen, M.-H. Wang, J.-H. Wang, C.-H. Hung, T.-H. Hu, S.-C. Lee, H.-D. Tung, C.-M. Lee, C.-S. Changchien, P.-F. Chen, et al. Aflatoxin Exposure and Hepatitis C Virus in Advanced Liver Disease in a Hepatitis C Virus Endemic Area in Taiwan Am J Trop Med Hyg, October 1, 2007; 77(4): 747 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Kirk, E. Bah, and R. Montesano Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa Carcinogenesis, October 1, 2006; 27(10): 2070 - 2082. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Scholl, P. C. Turner, A. E. Sutcliffe, A. Sylla, M. S. Diallo, M. D. Friesen, J. D. Groopman, and C. P. Wild Quantitative comparison of aflatoxin b1 serum albumin adducts in humans by isotope dilution mass spectrometry and ELISA. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 823 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Lleonart, G. D. Kirk, S. Villar, O. A. Lesi, A. Dasgupta, J. J. Goedert, M. Mendy, M. C. Hollstein, R. Montesano, J. D. Groopman, et al. Quantitative Analysis of Plasma TP53 249Ser-Mutated DNA by Electrospray Ionization Mass Spectrometry Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2956 - 2962. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Kirk, P. C. Turner, Y. Gong, O. A. Lesi, M. Mendy, J. J. Goedert, A. J. Hall, H. Whittle, P. Hainaut, R. Montesano, et al. Hepatocellular Carcinoma and Polymorphisms in Carcinogen-Metabolizing and DNA Repair Enzymes in a Population with Aflatoxin Exposure and Hepatitis B Virus Endemicity Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 373 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E Moore, A. J. Fulford, P K. Streatfield, L. A. Persson, and A. M Prentice Comparative analysis of patterns of survival by season of birth in rural Bangladeshi and Gambian populations Int. J. Epidemiol., February 1, 2004; 33(1): 137 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Wang, S. Abubaker, X. He, G. Sun, P. T. Strickland, and J. D. Groopman Development of Aflatoxin B1-Lysine Adduct Monoclonal Antibody for Human Exposure Studies Appl. Envir. Microbiol., June 1, 2001; 67(6): 2712 - 2717. [Abstract] [Full Text] |
||||
![]() |
V. Preisler, W. J. Caspary, F. Hoppe, R. Hagen, and H. Stopper Aflatoxin B1-induced mitotic recombination in L5178Y mouse lymphoma cells Mutagenesis, January 1, 2000; 15(1): 91 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Groopman and T. W. Kensler The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight? Carcinogenesis, January 1, 1999; 20(1): 1 - 11. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |